Events2Join

Physicochemical and biological characterization of SB2


Physicochemical and biological characterization of SB2, a biosimilar ...

A biosimilar is a biological medicinal product that contains a version of the active substance of an already authorized original biological medicinal ...

Physicochemical and biological characterization of SB2, a biosimilar ...

SB2 was similar to the RP in terms of tumor necrosis factor–α (TNF-α) binding and TNF-α neutralization activities as a main mode of action.

Physicochemical and biological characterization of SB2, a biosimilar ...

Biosimilarity to the reference product (RP) in terms of quality characteristics, such as physicochemical and biological properties, safety, and ...

Evaluation of the structural, physicochemical, and biological ...

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab) · Chemistry, Medicine. mAbs · 2017.

A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical ...

Analysis of the antigen-binding fragment (Fab)-related biological activity of SB2 has demonstrated that these differences in physicochemical properties between ...

European Journal of Pharmaceutical Sciences - Lirias

Physicochemical and biological characterization of SB2, a biosi- · milar of Remicade(R) (infliximab). MAbs 9 (2), 364–382. Lee, C., et al ...

A randomised, double-blind, phase III study comparing SB2, an ...

8 First, a comprehensive physicochemical and biological characterisation6 is ... Physicochemical characterization of Remsima. MAbs 2014;6:1163–77. doi ...

Summarized attributes and key findings. | Download Table

Download Table | Summarized attributes and key findings. from publication: Physicochemical and biological characterization of SB2, a biosimilar of Remicade® ...

Physicochemical and biological characterization of SB2, a biosimilar ...

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). scientific article published on 22 December 2016. In more ...

Evaluation of the physicochemical and biological stability of ...

ABSTRACT. Objectives To evaluate the critical quality attributes that might affect the stability of an infliximab biosimilar. (SB2 ...

Physicochemical and biological characterization of a biosimilar ...

Physicochemical and biological characterization of a biosimilar trastuzumab. López-Morales, C.A.; Miranda-Hernández, M.P.; Juárez-Bayardo, L.C.; ...

SB2: An Infliximab Biosimilar - OUCI

Hong J, Lee Y, Lee C, et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). mAbs. 2017;9(2):365–83.

[PDF] Batch-to-Batch Consistency of SB4 and SB2, Etanercept and ...

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab) · Juyong HongYuh-Chuang Lee +13 authors. Orlando Jaquez.

Batch-to-Batch Consistency of SB4 and SB2, Etanercept and ...

Hong J, Lee Y, Lee C, Eo S, Kim S, Lee N, et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade(R) (infliximab) ...

Physicochemical and Biological Characterization of RTXM83, a New ...

Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with ...

process defines the product: what really matters in biosimilar design ...

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). MAbs 2017;9:365–38 [63], with permission ...

Insight into Biosimilars: Short Description, Analytical Assessment ...

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). MAbs. 2017 Feb/Mar;9(2):364-382. doi ...

Evaluation of the structural, physicochemical, and biological ...

This comprehensive characterization study demonstrated that SB4 is highly similar to the reference product, Enbrel®, in structural, physicochemical, and ...

Analytical Similarity Assessment of Biosimilars: Global Regulatory ...

Physicochemical and Biological Characterization of SB2, a Biosimilar of Remicade (Infliximab). MAbs 9, 365–383. doi:10.1080/19420862.2016.1264550. CrossRef ...

An in vitro comparison of four different immunoassays for the ...

Kim, N. Lee, et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade(R) (infliximab). MAbs, 9 (2) (2017), pp. 364-382. View in ...